Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19061520 | 0.98 | KDM4E (0.34) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL17714891 | 0.97 | PTGER4 (0.34) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL19061509 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL17714885 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL19061500 | 0.96 | PDE10A (0.33) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL19061651 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL19061316 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2AVPR1A | |
| SCHEMBL24273004 | 0.95 | RXRA (0.32) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL22386969 | 0.95 | RXRA (0.32) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL22386993 | 0.95 | RXRA (0.32) | KDM4EATML3MBTL1PDK2HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111231-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2021-09-07 | — | — | US | disclosed |
| EP-3015465-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-09-04 | — | — | EP | disclosed |
| US-20190127352-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-02 | — | — | US | disclosed |
| US-10253016-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2019-04-09 | — | — | US | disclosed |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| EP-3015465-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2016-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10253016-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CRY2, NR2E3 | KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885 |
| US-20160204359-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, NR2E3 | KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885 |
| US-11111231-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRY1, CRY2, NR2E3 | KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885 |
| US-20190127352-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, NR2E3 | KDM4E 1531/4885ATM 2327/4885L3MBTL1 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.